U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Points to Consider for Portable Blood Glucose Monitoring Devices Intended for Bedside Use in the Neonate Nursery
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Points to Consider for Portable Blood Glucose Monitoring Devices Intended for Bedside Use in the Neonate Nursery February 1996

Final
Issued by:
Guidance Issuing Office
Center for Devices and Radiological Health

This document presents approaches to addressing the current major concerns about blood glucose monitoring devices intended for bedside use in the neonate nursery (BGM-N). It is based on: 1) current science; 2) clinical experience; 3) previous submissions from manufacturers to the Food and Drug Administration (FDA); 4) the Safe Medical Devices Act of 1990; and 5) regulations in the Code of Federal Regulations (CFR).


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.